The influence of pre-stenting and drugs on the outcomes of ureteroscopy for kidney and ureteral stone disease: a systematic review and meta-analysis by the EAU Section of Endourology
Authors:
- Steffi Kar Kei YuenSYSteffi Kar Kei Yuen
- Daniele CastellaniDCDaniele Castellani
- Theodoros TokasTTTheodoros Tokas
- Giacomo Maria PirolaGPGiacomo Maria Pirola
- Carlo GiulioniCGCarlo Giulioni
- Jia-Lun KwokJKJia-Lun Kwok
- Mohamed Amine LakmichiMLMohamed Amine Lakmichi
- Takafumi YanagisawaTYTakafumi Yanagisawa
- Amelia PietropaoloAmelia Pietropaolo
- Thomas HerrmannTHThomas Herrmann
- Bhaskar SomaniBSBhaskar Somani
- Vineet GauharVineet Gauhar
Open Access
- 12 August 2025
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-17
Abstract
Introduction: Ureteroscopy serves as a minimally invasive surgical treatment option for ureteral and kidney stones but is not without technical challenges. Pre-stenting and medical therapies, such as alpha-blockers, may improve outcomes by facilitating ureteral access sheath placements and reducing complications. This systematic review and meta-analysis aimed to evaluate the effects of pre-stenting and preoperative pharmacological agents on ureteroscopy outcomes. Methods: We conducted a systematic review and meta-analysis following PRISMA guidelines. A comprehensive literature search was performed across multiple databases, identifying randomized controlled trials comparing ureteroscopy outcomes with and without pre-stenting and pre-ureteroscopy medical therapy. Primary outcomes included failure rates in accessing the upper urinary tract, while secondary outcomes encompassed operative times, complications, and stone-free rates. Results: The analysis included 16 randomized controlled trials, revealing that pre-stenting and medical therapy significantly reduced failure rates (Relative Ratio 0.44, 95% CI 0.33–0.59, p < 0.001) and operative times (Mean Difference −10.81 min, 95% CI −13.45 to −8.18, p < 0.001). Additionally, there was a higher stone-free rates, lower need for postoperative stenting and fewer complications associated with preoperative ureteral dilation interventions. Conclusion: Preoperative alpha blockers enhance ureteroscopy success and reduces complications. The evidence supports their use before ureteroscopy for renal and ureteral stones, improving patient outcomes and procedural efficiency. Patients pre-stented for any reason demonstrated significantly improved ureteroscopic access and stone-free rates.Keywords
This publication has 45 references indexed in Scilit:
- Multicenter outcome analysis of different sheath sizes for Flexible and Navigable Suction ureteral access sheath (FANS) ureteroscopy: an EAU Endourology collaboration with the global FANS study groupUrolithiasis, 2024
- Successful treatment of staghorn stones with flexible ureteroscopy and thulium fiber laser (TFL) lithotripsy: initial experience with 32 casesUrolithiasis, 2024
- Semirigid ureteroscopy and tamsulosin therapy as dilatation methods before flexible ureteroscopy: evaluation and benefitsWorld Journal of Urology, 2024
- Multiarm studies and how to handle them in a meta‐analysis: A tutorialCochrane Evidence Synthesis and Methods, 2023
- The Ureteral Response to Ureteral Stents2023
- Complications of ureteroscopy: a complete overviewWorld Journal of Urology, 2019
- Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year periodWorld Journal of Urology, 2019
- Do alpha-1 antagonist medications affect the success of semi-rigid ureteroscopy? A prospective, randomised, single-blind, multicentric studyUrolithiasis, 2017
- Alpha-blockers as medical expulsive therapy for ureteral stonesCochrane Database of Systematic Reviews, 2014
- Impact of ureteral stenting prior to ureterorenoscopy on stone-free rates and complicationsWorld Journal of Urology, 2011